MEDICARE AND MEDICAID government reimbursement programs began with the best of intentions in 1965 at a modest cost to the U.S. taxpayer. No one in those early years was able to predict the steady growth of healthcare expenditures that would occur in subsequent years. For example, during the 1970s health care costs rose from 7.5 percent of the U.S. gross national product (GNP) to 9.4 percent in 1980. Estimates of the cost for 1985 predict that expenditures will consume 11.2 percent of the GNP, or an outlay of 414 billion dollars! Since 1965, the average yearly rise in health care costs has been 9-15 percent, a rate that far exceeds our annual inflation rate.
Finally, in 1983 Congress passed a cost-containment program that incorporates a prospective payment plan for Medicare inpatient hospital services. It is expected that in the coming years alI third-party insurance carriers will also develop prospective payment plans, which, like the Medicare Program, will reimburse hospitals at a predetermined flat rate based on the admitting diagnosis for a particular patient, which categorizes patients into diagnosis-related groups (DRGs).
For the pharmacy service of the hospital, this means that the director can no longer justify old or new programs based on selling drugs for profit. In the future, pharmacy department (and hospital) profits will be determined by the true cost efficiency of each program. The only way to increase profitability will be to: (1) reduce inventory, (2) reduce acquisition costs, (3) reduce personnel, (4) reduce overhead, (5) and increase productivity. ROBERT Intravenous admixture programs that include the preparation of injectable drugs for intermittent infusion have enjoyed rapid growth in the U.S., with the most popular system using the minibag concept. Unfortunately, this system was justified mainly as an incomeproducing program for hospitals and was not based on increased patient safety or increased cost efficiency. The following review of methods for intermittent drug delivery discusses the various systems used.
Intermittent Drug Administration
Most bactericidal antibiotics are given by intermittent dosing rather than continuous infusion so that a "peak and valley" drug serum level effect occurs. There are other reasons for the intermittent use of antibiotics, e.g., to prevent post-infusion phlebitis from drugs irritating to the vein endothelium. Intermittent dosing provides a rest period where the drug is not in contact with the vein.' Second, peak levels of the drug in the serum promote higher tissue penetration.
Intermittent administration of intravenous medication can be accomplished in a variety of ways, including: (1) iv bolus, (2) an auxiliary medication set, (3) a minibag or minibottle or (4) manufacturer's piggyback bottles.
THE INTRAVENOUS BOLUS METHOD
With this method, the nurse prepares the syringe of drug on the floor, or, if the pharmacy has a unit-dose system, the dose is prepared in the pharmacy, labeled, and sent to the floor. The nurse then either performs a primary venipuncture or injects the drug into the tub-ing of a running iv solution. When giving such a bolus of drug by the direct intravenous method, very high serum concentrations are achieved and care must be taken that the administration rate of the drug solution does not exceed the manufacturer's maximum rate shown in the package insert. 2 Administering drugs directly into the vein often is restricted to a physician, except in special areas such as intensive care units and postoperative recovery areas.
THE AUXILIARY MEDICATION SET
The small volumes of intravenous fluids needed by infants led to the development of the auxiliary medication set. This set has since become popular for administering intermittent iv drugs. To use the medication set, an appropriate amount of the iv fluid is run into the metered chamber (e.g., 25-100 ml). Then the drug is injected into the medication additive port. Infusion of the drug then' proceeds over the specified infusion time. For patients on a number of iv drugs, entry into the chamber is frequent. Thus, the risk of contamination is great, and the set must be changed frequently to prevent growth of organisms.'
After the drug is injected into the chamber, specific identification is subsequently lost during administration. If a drug reaction were to occur, then the drug being administered at the time could not be identified. Drug incompatibilities can occur in the medication chamber or when incompatible drugs are present in the primary solution. If an iv medication that is incompatible with the intermittent drug is present in the primary container, a second bottle of fluid is necessary to fill the auxiliary medication chamber.
MINIBAGS AND MINIBOTTLES
Small volume containers, minibags and minibottles, are the most recent advances for intermittent administration. A special iv set is required with a built-in oneway valve on the primary set that closes when downstream hydrostatic pressure is greater from the piggyback container than from the primary container. For the piggyback or secondary container to generate greater hydrostatic pressure than the primary container, the primary container is hung lower, using a metal wire hanger. When the flow control clamp is properly adjusted, only the piggyback or secondary container will run. When the piggyback container empties, the primary container then begins to run. Although the valve set offers convenience, a Y-type set without the one-way valve can be used with piggybacks when cost is a significant consideration. This type of system has several advantages: (I) each dose of piggyback or intermittent medication is prepared in the pharmacy under appropriate environmental and quality control; (2) each container is labeled with the drug name, dose, rate of administration, precautions, and control number; (3) some in vitro studies have shown this system to be safer than the auxiliary medication administration set, which has a high intrinsic contamination rate;" other studies have shown conflicting results.'> There are major disadvantages with this system. There is a risk of fluid overload when patients are receiving multiple intravenous drugs. There is also an inability to select other diluents besides 5010 dextrose or NaCI 0.9%. In the case of 5% dextrose, the patient receives 100 percent free water and in the case of NaCl 0.9%, the patient receives no free water. Since the pharmacist cannot select diluents such as sterile water for injection or NaCI 0.45%, some drugs, particularly the ,8-lactam antibiotics, may be hypertonic, with osmolarities > 600 mOsm/L. Finally, there is a higher cost per dose of iv medication, since the cost of each minibag is $1.20-1.50, in addition to the cost of the drug.
MANUFACTURER'S PIGGYBACK CONTAINERS (MPC)
With this system, the pharmacist can add up to 100 ml of diluent, and appropriate labeling and quality control can be maintained at a reduced cost because most manufacturers sell the piggyback bottle at a moderate cost, ranging from $0.25-0.60.
In general, the pharmacy department should be able to prepare MPCs as efficiently as plastic mini bags and at a significant cost savings to the hospital. Savings per dose of drug should be $0.60-0.80, depending on the hospital's present contract for minibags. For example, a 5OO-bed hospital preparing 200 minibags per day could convert 50-70 percent of the doses of MPCs and, even at a modest cost savings of $0.75 per dose, could reduce expenditures by over $32000 a year.
There is an additional advantage for the patient in such a system because with MPCs the pharmacist can choose the diluent that allows the infusion of the most isotonic solutions.
New Systems for Intermittent Drug Delivery
Because of the high cost of using mini bags in a drug delivery system, various individuals and manufacturers are exploring new methods to administer intermittent iv drugs.
The Medifuse IV Administration system (3-M Medical Products Division, St. Paul, MN) consists of three basic components. A flow-regulating set, a syringe, and a spring-operated infusor. The disposable set is the rate control component of the system and is available in a variety of color-coded iv sets. A table is provided for each drug that includes specific flow rates for different drug concentrations. The device appears to be quite cost effective and carries the additional benefit of not having to interrupt the primary iv since the drug is infused into the tubing (Y-site) of the primary running iv.'
The Harvard Mini-Infusor System (C.R. Bard, Murray Hill, NJ) consists of a battery-operated syringe pump and microbore extension set. Here, the pharmacist fills the syringe with the drug and the nurse places the syringe into the pump, sets the rate, and administers the drug into the tubing (Y-site) of a primary running iv solution. A hospital with 500 beds would probably require several hundred of these devices to meet their medication administration needs.
The Quest Add-Vent System (Quest Medical, Dallas, TX) is a syringe administration system with a syringe, the Quest 2001 Infusor, and a secondary medication administration set that attaches directly to the end of the syringe. The set contains an air-vent that allows the nurse to use the syringe just as one would a mini bag or minibottle. The syringe is placed in a plastic bag with a hole at the bottom where the end of the syringe is exposed. The nurse attaches the set to the syringe, hangs the syringe in the bag (just as a minibag is hung-higher than the primary container) and sets the volume and rate of administration into the infusion device. When the medication delivery is completed, the infusor automatically switches back to the primary iv solution at the appropriate rate for that solution. The syringe system will also work without the infusion device, just as a minibottle or minibag would, using the force provided by gravity. As with other systems where the pharmacist chooses the diluent, each drug can be prepared so that most infusions are reasonably isotonic.
Summary
Cost effectiveness in all aspects of hospital care is necessary for survival in the 1980s. Under the new prospective payment system, the emphasis will switch from selling at a profit to increasing profits by spending less. Pharmacists need to reexamine available alternatives and new horizons in each area of distributive services, especially in the way we dispense and administer intermittent intravenous drugs.
Manufacturer's piggyback containers are readily available for about 60 percent of required doses, and significant cost savings could result in a relatively short period of time. Newer systems that use syringes should also be explored and an in-hospital evaluation program set up to decide which is the most cost-effective, accept 
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